199 lines
No EOL
103 KiB
XML
199 lines
No EOL
103 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK559007" /><meta name="ncbi_domain" content="statpearls" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK559007/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Bacterial Pharyngitis - StatPearls - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="StatPearls [Internet]" /><meta name="citation_title" content="Bacterial Pharyngitis" /><meta name="citation_publisher" content="StatPearls Publishing" /><meta name="citation_date" content="2024/10/06" /><meta name="citation_author" content="Seneca Harberger" /><meta name="citation_author" content="Jennifer Goldin" /><meta name="citation_author" content="Matthew Graber" /><meta name="citation_pmid" content="32644433" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK559007/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Bacterial Pharyngitis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="StatPearls Publishing" /><meta name="DC.Contributor" content="Seneca Harberger" /><meta name="DC.Contributor" content="Jennifer Goldin" /><meta name="DC.Contributor" content="Matthew Graber" /><meta name="DC.Date" content="2024/10/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK559007/" /><meta name="description" content="Pharyngitis, an inflammation of the pharynx resulting in a sore throat, is a common condition primarily attributed to noninfectious or viral causes. However, identifying and treating bacterial pharyngitis is pivotal in preventing potential long-term complications. With the etiology of sore throat varying across age groups, a strategic assessment becomes imperative to discern patients who require testing and treatment for bacterial causes, are potentially at risk for sexually transmitted infections like HIV, or harbor life-threatening conditions inducing airway obstruction or death. Distinguishing between viral and bacterial pharyngitis can be challenging as their symptoms may overlap." /><meta name="og:title" content="Bacterial Pharyngitis" /><meta name="og:type" content="book" /><meta name="og:description" content="Pharyngitis, an inflammation of the pharynx resulting in a sore throat, is a common condition primarily attributed to noninfectious or viral causes. However, identifying and treating bacterial pharyngitis is pivotal in preventing potential long-term complications. With the etiology of sore throat varying across age groups, a strategic assessment becomes imperative to discern patients who require testing and treatment for bacterial causes, are potentially at risk for sexually transmitted infections like HIV, or harbor life-threatening conditions inducing airway obstruction or death. Distinguishing between viral and bacterial pharyngitis can be challenging as their symptoms may overlap." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK559007/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-statpearls-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/statpearls/article-27105/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK559007/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C60197D87DF410000000000FE00E2.m_5" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-part">
|
||
<div class="grid no_max_width">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
|
||
<div class="header">
|
||
|
||
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<div class="container content">
|
||
<div class="document">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. </p></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK559007_"><span class="title" itemprop="name">Bacterial Pharyngitis</span></h1><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Seneca Harberger</span>; <span itemprop="author">Jennifer Goldin</span><sup>1</sup>; <span itemprop="author">Matthew Graber</span><sup>2</sup>.</p><h4>Affiliations</h4><div class="affiliation"><sup>1</sup> Wright State University School of Medicine</div><div class="affiliation"><sup>2</sup> Magnolia Regional Health Center</div><p class="small">Last Update: <span itemprop="dateModified">October 6, 2024</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="article-27105.s1"><h2 id="_article-27105_s1_">Continuing Education Activity</h2><p>Respiratory viral pathogens predominate as culprits of infectious pharyngitis, characterized by inflammation of the pharynx leading to a sore throat. However, bacterial etiologies hold clinically important significance. Despite most cases being self-limited, identifying bacterial pharyngitis is imperative to avert potential long-term complications like rheumatic fever and glomerulonephritis. Among bacterial causes, Group A β-hemolytic <i>Streptococcus</i> or <i>Streptococcus pyogenes</i><i> </i>is the most common bacterial cause. </p><p>Viral and bacterial pharyngitis have overlapping symptoms. Thus, clinicians should not depend solely on physical examination to establish the diagnosis of group A β-hemolytic streptococcal infection. Rapid antigen detection, nucleic acid amplification testing, or throat culture is necessary to confirm the diagnosis. The presence of a runny nose, cough, mouth ulcers, a viral exanthem, conjunctivitis, or hoarse voice typically eliminates the need for testing and points toward a viral origin. The Centor criteria can help determine who needs group A β-hemolytic <i>Streptococcus </i>testing when the presentation is unclear.</p><p>Though less common, additional causes of bacterial pharyngitis are group C and G streptococci, sexually transmitted infections like <i>Neisseria gonorrhea </i>and <i>Treponema pallidum, <i>Corynebacterium diphtheriae</i> </i>in places where vaccination rates are low, <i>Mycoplasma pneumoniae, </i>and <i>Chlamydia pneumoniae</i><i>. </i>These alternatives<i> </i>should be considered based on the patient's physical examination, sexual, travel, and vaccination history or when a patient fails to improve after treatment with standard therapy.</p><p>This activity for healthcare professionals is designed to enhance the learner’s competence when diagnosing and managing bacterial pharyngitis, leading to improved clinical decision-making, accurate identification of bacterial infections, and appropriate utilization of diagnostic tools, thereby reducing unnecessary testing and treatment. Participants gain a deeper insight into the condition's clinical manifestations, diagnostic strategies, and therapeutic interventions. By navigating the intricacies of diagnosing bacterial pharyngitis, clinicians can optimize patient care, mitigate antibiotic overuse and resistance, and enhance healthcare outcomes. Greater proficiency increases the learner's ability to collaborate within an interprofessional team caring for patients with bacterial pharyngitis.</p><p>
|
||
<b>Objectives:</b>
|
||
<ul><li class="half_rhythm"><div>Identify the clinical features suggestive of bacterial pharyngitis.</div></li><li class="half_rhythm"><div>Implement appropriate diagnostic tests for bacterial pharyngitis. </div></li><li class="half_rhythm"><div>Create an individualized, evidence-based treatment plan for a patient diagnosed with bacterial pharyngitis.</div></li><li class="half_rhythm"><div>Collaborate with the healthcare team to develop and implement strategies for appropriate antibiotic stewardship in managing bacterial pharyngitis, ensuring optimal patient outcomes while minimizing antibiotic resistance and adverse effects.</div></li></ul>
|
||
<a href="https://www.statpearls.com/account/trialuserreg/?articleid=27105&utm_source=pubmed&utm_campaign=reviews&utm_content=27105" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Access free multiple choice questions on this topic.</a>
|
||
</p></div><div id="article-27105.s2"><h2 id="_article-27105_s2_">Introduction</h2><p>Pharyngitis, an inflammation of the pharynx resulting in a sore throat, is a common condition primarily attributed to noninfectious or viral causes. However, identifying and treating bacterial pharyngitis is pivotal in preventing potential long-term complications. With the etiology of sore throat varying across age groups, a strategic assessment becomes imperative to discern patients who require testing and treatment for bacterial causes, are potentially at risk for sexually transmitted infections like HIV, or harbor life-threatening conditions inducing airway obstruction or death. Distinguishing between viral and bacterial pharyngitis can be challenging as their symptoms may overlap.</p><p>Group A β-hemolytic <i>Streptococcus</i> (GABS), or <i>Streptococcus pyogenes</i>, is the leading cause of bacterial pharyngitis, potentially leading to serious complications like retropharyngeal abscess, meningitis, rheumatic fever, glomerulonephritis, and toxic shock syndrome if untreated. Accurate identification of bacterial pharyngitis and determining when to investigate less common causes are crucial for preventing unnecessary testing, treatment, and complications from untreated infections.<a class="bk_pop" href="#article-27105.r1">[1]</a> </p><p>While the goals of antibiotic therapy for bacterial pharyngitis are symptom alleviation, complication prevention, and interruption of transmission, reliance solely on physical examination for diagnosing GABS infection is inadequate. Instead, confirmatory tests such as rapid antigen detection testing (RADT), nucleic acid amplification testing (NAAT), and throat culture become indispensable. Concurrent symptoms like rhinorrhea, cough, oral ulcers, viral exanthem, conjunctivitis, and hoarseness typically favor a viral etiology, eliminating the need for testing.</p><p>The Centor criteria offer valuable guidance in determining the necessity of GABS testing in ambiguous presentations. Although less prevalent, sexually transmitted infections like <i>Neisseria gonorrhea</i> and <i>Treponema pallidum</i>, <i>Corynebacterium diphtheriae</i> in undervaccinated regions, and zoonotic agents like <i>Francisella</i> <i>tularensis</i> and <i>Yersinia pestis</i> pose alternative considerations based on clinical evaluation and patient history.</p></div><div id="article-27105.s3"><h2 id="_article-27105_s3_">Etiology</h2><p>Acute pharyngitis is quite common in children and adults. Common noninfectious causes are allergic rhinitis or sinusitis, gastroesophageal reflux disease, smoking or exposure to second-hand smoke, and exposure to dry air. In addition, Kawasaki disease, Behçet syndrome, chemotherapy agents, and angiotensin-converting enzyme inhibitors also produce symptoms of pharyngitis.<a class="bk_pop" href="#article-27105.r2">[2]</a></p><p>GABS are gram-positive cocci arranged in chains or pairs and are the most common bacterial etiology of pharyngitis, producing what is commonly referred to as "strep throat."<a class="bk_pop" href="#article-27105.r3">[3]</a> Transmitted via airborne transmission or ingestion, the only known reservoirs of GABS are human skin and mucous membranes. Infection generally peaks in winter and early spring and is most common in school-age children. Additional causes of bacterial pharyngitis include the following:</p><ul><li class="half_rhythm"><div>Group C and G <i>Streptococcus</i>: These organisms present identically to GABS, most frequently affect college students and young adults, and are associated with community and foodborne outbreaks.</div></li><li class="half_rhythm"><div><i>Neisseria gonorrhea</i>:<i> </i>A gram-negative coccus generally acquired by oral sexual exposure. Pharyngitis associated with <i>N gonorrhea</i><i> </i>occurs<i> </i>most commonly in men who have sex with men.<a class="bk_pop" href="#article-27105.r4">[4]</a></div></li><li class="half_rhythm"><div><i>Chlamydia trachomatis</i>: This gram-negative rod does not typically cause pharyngitis, but the pharynx can be a reservoir for infection.</div></li><li class="half_rhythm"><div><i>Treponema pallidum</i>:<i> </i>A spirochete bacterium transmitted sexually. Pharyngitis is a common presenting symptom in patients with secondary syphilis.</div></li><li class="half_rhythm"><div><i>Arcanobacterium haemolyticum</i><i> </i>(formerly <i>Corynebacterium haemolyticum</i>): This uncommon cause of pharyngitis is an anaerobic gram-positive bacillus spreading through infected respiratory droplets, especially in adolescents and young adults.</div></li><li class="half_rhythm"><div><i>Fusobacterium necrophorum</i>: A gram-negative rod that often colonizes the oropharynx and is likely a secondary invader rather than a causative pathogen.</div></li><li class="half_rhythm"><div><i>Mycoplasma pneumoniae </i>and <i>Chlamydia pneumoniae:</i><i> </i>Both spread via respiratory droplets. <i>M. pneumoniae </i>is a short rod with no cell wall and is not visible on gram stain<i>. C pneumoniae</i> is a gram-negative bacteria. Pharyngitis is most common in children and young adults and often occurs with a lower respiratory tract infection.</div></li><li class="half_rhythm"><div><i>Corynebacterium diphtheria</i>:<i> </i>A gram-positive club-shaped bacillus transmitted via infected respiratory droplets. Diphtheria is rare in the United States and other places with high immunization rates.<a class="bk_pop" href="#article-27105.r5">[5]</a><a class="bk_pop" href="#article-27105.r6">[6]</a><a class="bk_pop" href="#article-27105.r7">[7]</a></div></li><li class="half_rhythm"><div><i>Francisella tularensis</i>:<i> </i>This organism is a gram-negative coccobacillus that causes pharyngeal tularemia. Infection occurs via the skin when handling infected animal tissue or inhaling contaminated dust or aerosols.</div></li><li class="half_rhythm"><div><i>Yersinia pestis: </i>This organism is a gram-negative coccobacillus, transmitted by fleas, that causes the plague. </div></li></ul><p>Pharyngitis has a broad differential, encompassing both infectious and noninfectious etiologies, thus requiring careful evaluation of symptoms and risk factors. Identifying the underlying cause is essential for appropriate management and prevention of complications.</p></div><div id="article-27105.s4"><h2 id="_article-27105_s4_">Epidemiology</h2><p>Pharyngitis is a widespread complaint in healthcare professionals' offices, emergency departments, and urgent care centers, accounting for approximately 12 million annual visits in the United States.<a class="bk_pop" href="#article-27105.r8">[8]</a> This figure represents 1% to 2% of all outpatient visits. Nearly 50% of these visits occur in children, with the remaining adult cases peaking by age 40.<a class="bk_pop" href="#article-27105.r9">[9]</a><a class="bk_pop" href="#article-27105.r10">[10]</a></p><p>Viral causes account for 70% to 90% of acute cases, primarily driven by rhinovirus, the cause of the common cold. GABS infection constitutes 5% to 15% of cases of acute pharyngitis in developed countries and is more common in school-age children. Group C and G streptococci comprise 5% to 10%, while <i>A haemolyticum </i>accounts for 1% to 2.5% of cases.<a class="bk_pop" href="#article-27105.r11">[11]</a><a class="bk_pop" href="#article-27105.r12">[12]</a></p><p>The exact prevalence of <i>M pneumoniae </i>and <i>C pneumoniae </i>is unknown. Unvaccinated populations or regions of the world where the disease remains endemic confine cases of diphtheria. Most pharyngeal infections with <i>N gonorrhea </i>are asymptomatic. Studies reveal the prevalence of pharyngeal gonorrhea in men who have sex with men is approximately 15%.<a class="bk_pop" href="#article-27105.r13">[13]</a> Antibiotic prescriptions are given to 49% to 57% of children and 64% of adults with pharyngitis, often exceeding the prevalence of bacterial infection warranting treatment.<a class="bk_pop" href="#article-27105.r14">[14]</a>  </p></div><div id="article-27105.s5"><h2 id="_article-27105_s5_">Pathophysiology</h2><p>Bacteria invade the mucosal tissues of the pharynx directly. The remaining details of the pathogenesis of bacterial pharyngitis vary based on the underlying pathogen.</p><p>
|
||
<b>Group A β-Hemolytic <i>Streptococcus</i></b>
|
||
</p><p>GABS has a number of virulence factors that subvert the host's natural immune response. Cell surface proteins, hemolytic toxins, pyrogenic exotoxins, and bacterial structural components all contribute to its virulence. M and M-like proteins help the organism evade phagocytosis and complement deposition.<a class="bk_pop" href="#article-27105.r15">[15]</a> Toxins like streptolysin O further exacerbate tissue damage by affecting platelets and endothelial cells, leading to ischemic injury.<a class="bk_pop" href="#article-27105.r16">[16]</a> Streptolysin S lyses red blood cells. Hyaluronidase aids in infection spread along fascial planes by breaking down hyaluronic acid in connective tissue.</p><p>All GABS strains secrete streptokinase and have plasminogen binding sites on the surface. When plasminogen binds, streptokinase converts plasminogen to plasmin and interrupts the coagulation cascade, aiding the spread of infection to deep tissues.<a class="bk_pop" href="#article-27105.r17">[17]</a> Streptokinase is also involved in the development of poststreptococcal glomerulonephritis. Some strains secrete S<i>treptococcus pyogenes</i> nicotinamide-adenine dinucleotidase, which is translocated into the host cells to deplete nicotinamide adenine dinucleotide stores. See StatPearls' companion reference, "<a href="https://www.statpearls.com/point-of-care/22287" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Poststreptococcal Glomerulonephritis</a>," for additional information regarding the pathophysiology of poststreptococcal glomerulonephritis. </p><p>Streptococcal pyrogenic exotoxins elicit lymphocyte blastogenesis, exacerbate endotoxin-induced shock, cause fever, dampen antibody synthesis, and function as superantigens. The toxins contribute to fever and shock by reducing the threshold for endotoxin effects, prompting human mononuclear cells to produce tumor necrosis factor-α, interleukin-1, and interleukin-6.</p><p>Streptococcal pyrogenic exotoxins also contribute to scarlet fever and toxic shock syndrome by acting as superantigens and stimulating T-cell responses.<a class="bk_pop" href="#article-27105.r18">[18]</a> Binding occurs at both the class II major histocompatibility complex of antigen-presenting cells and the V β region of the T-cell receptor, prompting T cells to synthesize interleukin-1, tumor necrosis factor-α, tumor necrosis factor-β, interleukin-6, and interferon-γ. See StatPearls' companion references, "<a href="https://www.statpearls.com/point-of-care/30298" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Toxic Shock Syndrome</a>" and "<a href="https://www.statpearls.com/point-of-care/28741" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Scarlet Fever</a>," for more detailed information regarding the pathogenesis of these complications related to GABS infection. </p><p>
|
||
<b>Other Bacterial Causes</b>
|
||
</p><p>Less common bacterial agents that cause acute pharyngitis include <i>C diphtheria, <i>N gonorrhea, <i>T pallidum, and <i>M pneumoniae. </i></i></i></i>Each of these pathogens presents distinct pathophysiological mechanisms, influencing both diagnosis and treatment approaches.</p><p>
|
||
<b>
|
||
<i>Corynebacterium diphtheria</i>
|
||
</b>
|
||
</p><p>Diphtheria symptoms result from local respiratory tract inflammation and the effects of exotoxin both locally and systemically. The toxin binds to cell membrane receptors and disrupts protein synthesis by inactivating elongation factor 2, leading to cell death.</p><p>
|
||
<b>
|
||
<i>Neisseria gonorrhea</i>
|
||
</b>
|
||
</p><p>
|
||
<i>N gonorrhea</i> attaches to the host urethral, cervical, or other epithelial cells via type IV pili and other surface proteins. The pili and surface proteins undergo antigenic variation and various other complex processes to avoid detection by the host immune system.<a class="bk_pop" href="#article-27105.r19">[19]</a> Once bound to the host cells, the organism becomes internalized, multiplies, and divides intracellularly, protecting itself from the immune system and the local environment. Gonococcal infection dampens the host's immune response, preventing the formation of protective immunity against future infections.</p><p>
|
||
<b>
|
||
<i>Treponema pallidum</i>
|
||
</b>
|
||
</p><p>
|
||
<i>T pallidum </i>causes infection wherever inoculation occurs. Primary syphilis presents as a painless chancre at the site of inoculation after an incubation period of 3 to 6 weeks. The chancre initially contains polymorphonuclear leukocytes, which are quickly replaced by T lymphocytes. Concurrently, the host develops a humoral immune response, leading to the development of antibodies detected early in the disease course. While the immune response eliminates the chancre, it does not control the dissemination of the spirochete throughout the body in untreated patients. </p><p>
|
||
<b>
|
||
<i>Mycoplasma pneumoniae</i>
|
||
</b>
|
||
</p><p>The underlying pathophysiology of <i>M. pneumoniae </i>pharyngitis is not fully understood. <i>M pneumoniae </i>has a selective affinity for the respiratory epithelium<i>. </i>Once bound,<i> M pneumoniae </i>secretes hydrogen peroxide and superoxide, which damages the epithelial cells and their cilia. Some remain on the cell surface, and some can invade the host cells, protected from the host's immune response.<a class="bk_pop" href="#article-27105.r20">[20]</a> Extrapulmonary manifestations like hemolysis and encephalitis may be due to antibodies produced against the glycolipid antigens of <i>M pneumoniae</i> that cross-react with human red cells and brain cells and act as autoantibodies. See StatPearls' companion references, "<a href="https://www.statpearls.com/point-of-care/27269" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Plague</a>" and " <a href="https://www.statpearls.com/point-of-care/30676" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Tularemia</a>," for specific details regarding the pathophysiology of <i>Y.</i><i> pestis- </i>and<i> F tularensis-</i>induced disease.</p><p>Recognizing the diverse bacterial causes of acute pharyngitis is essential for effective treatment. Each pathogen's unique infectious mechanisms require tailored approaches to ensure proper management and reduce the risk of complications.</p></div><div id="article-27105.s6"><h2 id="_article-27105_s6_">History and Physical</h2><p>The initial history and physical examination help clinicians exclude potentially life-threatening conditions and identify treatable causes of pharyngitis. Key historical features for diagnosing pharyngitis include the rapidity of onset and the presence or absence of symptoms such as respiratory distress, fever, and fatigue. Additional relevant factors are recent exposure to sick contacts, history of immunocompromised conditions, vaccination and travel history, sexual history, and previous episodes of pharyngitis. Fever suggests an infectious cause, and respiratory distress indicates an obstructive process like epiglottitis or retropharyngeal or peritonsillar abscess. Pharyngitis, fever, and severe fatigue may indicate infectious mononucleosis. </p><p>
|
||
<b>Group A β-hemolytic <i>Streptococcus</i> </b>
|
||
</p><p>Pharyngitis caused by GABS in children 3 years or older typically has an abrupt onset accompanied by fever, headache, and abdominal pain, occasionally associated with nausea and vomiting. Children younger than 3 often do not have a clearly defined case of pharyngitis. These patients may also have accompanying nasal congestion and discharge. Infants younger than 1 year often present with fussiness, decreased appetite, and low-grade fever. These patients often have a family member or daycare contact with GABS. Adults tend to present with an acute-onset sore throat and fever.</p><p>Classic physical examination findings are exudative tonsillopharyngitis, enlarged tender anterior cervical lymph nodes, petechiae on the palate, and a strawberry tongue. Additionally, some patients may have a fine papular rash that begins in the groin and axilla, followed by spread to the trunk and extremities. The affected areas eventually undergo desquamation.<a class="bk_pop" href="#article-27105.r21">[21]</a> </p><p>
|
||
<b>
|
||
<i>Treponema pallidum</i>
|
||
</b>
|
||
</p><p>Primary syphilis presents as a chancre, or painless ulceration, at the site of inoculation. Approximately 25% of patients develop secondary syphilis, a systemic illness marked by rash, fever, headache, myalgias, pharyngitis, and gastrointestinal symptoms. Most patients also have posterior cervical, axillary, inguinal, and femoral lymphadenopathy. Epitrochlear nodes highly suggest the diagnosis. The rash, the most characteristic feature, is macular or papular and symmetric, involving the entire trunk and extremities, including the palms and soles.<a class="bk_pop" href="#article-27105.r22">[22]</a> </p><p>
|
||
<b>
|
||
<i>Mycoplasma pneumoniae</i> </b>
|
||
</p><p>
|
||
<i>M pneumoniae</i> presents in an atypical fashion for bacterial pharyngitis. Patients may experience symptoms similar to a viral upper respiratory infection, like a nonexudative sore throat, coryza, headache, ear pain, and a prolonged cough.<a class="bk_pop" href="#article-27105.r23">[23]</a> Physical examination findings may include pharyngeal edema, wheezing, otitis media, and other symptoms consistent with an upper respiratory infection. Others may have pharyngitis associated with pneumonia. Pneumonia associated with <i>M. pneumoniae </i>typically has a gradual onset, and the lung examination may be normal initially, with rales and wheezing developing later in the course. </p><p>
|
||
<b>
|
||
<i>Chlamydia Pneumoniae</i> </b>
|
||
</p><p>
|
||
<i>C pneumoniae</i> can cause various infections, including pharyngitis, laryngitis, otitis media, and bronchitis. In conjunction with pneumonia, upper respiratory symptoms like pharyngitis, laryngitis, or sinusitis may signify <i>a C pneumoniae</i> infection.</p><p>
|
||
<b>
|
||
<i>Corynebacterium diphtheria</i>
|
||
</b>
|
||
</p><p>Like GABS, diphtheria presents with a sore throat, malaise, cervical lymphadenopathy, and fever. Though the onset of diphtheria is gradual, additional symptoms may be hoarseness, cough, and purulent nasal discharge. The formation of a pseudomembrane can progress, causing respiratory stridor and death. Initially, patients exhibit mild pharyngeal edema and erythema followed by isolated gray and white exudate spots—approximately 33% progress to form a coalescing, tightly adherent pseudomembrane that bleeds with scraping.</p><p>
|
||
<b>
|
||
<i>Francisella tularensis</i>
|
||
</b>
|
||
</p><p>Pharyngeal tularemia presents with fever, severe sore throat, and swelling in the neck. Physical examination findings are exudative pharyngitis and tonsillitis with cervical lymph node enlargement. Distinguishing features are pharyngeal or tonsillar ulcers and a pharyngeal membrane mimicking diphtheria.<a class="bk_pop" href="#article-27105.r24">[24]</a></p><p>
|
||
<b>
|
||
<i>Yersinia pestis</i>
|
||
</b>
|
||
</p><p>
|
||
<i>Y</i>
|
||
<b>
|
||
<i> </i>
|
||
</b>
|
||
<i>pestis </i>most commonly presents as acute febrile lymphadenitis or bubonic plague. Rarely, if the patient has ingested <i>Y pestis</i>,<i> </i>the plague can manifest as pharyngitis and tonsillitis associated with anterior cervical lymphadenitis.<a class="bk_pop" href="#article-27105.r25">[25]</a></p></div><div id="article-27105.s7"><h2 id="_article-27105_s7_">Evaluation</h2><p>
|
||
<b>General Evaluation</b>
|
||
</p><p>Most of the evaluation for acute pharyngitis encompasses a comprehensive history and physical examination with testing in select patients. Clinicians begin with assessing vital signs for fever and evidence of clinical instability. A thorough otolaryngological examination evaluates the ears, conjunctiva, and nares for associated findings or referred symptoms mimicking pharyngitis.</p><p>Evaluation of the oropharynx and neck should assess for tonsilar and pharyngeal erythema, swelling, and exudates along with lymphadenopathy. Exudates or a pseudomembrane favors a bacterial etiology, as do swollen and tender anterior cervical lymph nodes. Conjunctivitis, swelling of the nasal turbinates, oral ulcers, and postnasal drip favor nonbacterial etiologies.<a class="bk_pop" href="#article-27105.r26">[26]</a> A skin examination revealing a red rash that feels like sandpaper indicates scarlet fever and GABS infection. Other rashes may suggest viral respiratory infections or syphilis.</p><p>When evaluating patients with acute pharyngitis, the initial step is to exclude life-threatening conditions like diphtheria or an abscess in the peritonsillar, submandibular, or retropharyngeal spaces requiring immediate intervention. These patients will be toxic-appearing, with fever and rigors. Additional findings may include the following:</p><ul><li class="half_rhythm"><div>A muffled voice, often referred to as a "hot potato" voice</div></li><li class="half_rhythm"><div>Hoarseness</div></li><li class="half_rhythm"><div>Drooling</div></li><li class="half_rhythm"><div>Stridor</div></li><li class="half_rhythm"><div>Sitting in a "tripod" position</div></li><li class="half_rhythm"><div>Tachypnea, dyspnea, or retractions</div></li><li class="half_rhythm"><div>Bulging of pharyngeal wall, soft palate, or floor of the oropharynx</div></li><li class="half_rhythm"><div>Crepitus</div></li><li class="half_rhythm"><div>Trismus</div></li><li class="half_rhythm"><div>Stiff neck</div></li></ul><p>Clinicians establish the diagnosis of viral pharyngitis based on the presence of cough, nasal congestion, conjunctivitis, coryza, oral ulcers, and viral exanthems. The associated complications and treatments differ for respiratory viral and bacterial pharyngitis. Thus, distinguishing between these conditions is essential.</p><p>
|
||
<b>Group A β-hemolytic <i>Streptococcus</i> Testing</b>
|
||
</p><p>Evaluating acute pharyngitis involves identifying specific symptoms and risk factors to determine the appropriate diagnostic tests. Testing decisions are guided by clinical criteria that help assess the likelihood of GABS infection and other causes.</p><p>
|
||
<b>Who to test</b>
|
||
</p><p>Adults with symptoms consistent with GABS pharyngitis like acute symptom onset, fever, tonsillopharyngeal or uvular edema, anterior cervical lymphadenitis, patchy tonsillar exudates, scarlatiniform skin rash, strawberry tongue, or a known exposure to GABS without typical respiratory virus symptoms should undergo microbiological testing for GABS. The Centor criteria help clinicians determine which adults to test if the decision is unclear. The Centor criteria include the following:</p><ul><li class="half_rhythm"><div>Tonsillar exudates</div></li><li class="half_rhythm"><div>Tender anterior cervical lymphadenopathy</div></li><li class="half_rhythm"><div>Fever</div></li><li class="half_rhythm"><div>Absence of cough</div></li></ul><p>Patients receive 1 point for each criterion they meet. Individuals who meet 3 or more criteria warrant testing for GABS.<a class="bk_pop" href="#article-27105.r27">[27]</a><a class="bk_pop" href="#article-27105.r28">[28]</a> Patients with fewer than 3 of these manifestations are less likely to have GABS pharyngitis, making further testing unnecessary. Clinicians should remember that the Centor criteria have low sensitivity, and they should not bypass their clinical impressions to determine the need for antibiotic therapy. The McIsaac criteria derive from the original Centor criteria but account for age differences by adding a point for patients aged 3 to 14 and subtracting a point for patients aged 45 or older.<a class="bk_pop" href="#article-27105.r29">[29]</a></p><p>The FeverPAIN criteria include fever, tonsillar exudates, severe inflammation, onset within 3 days, and the absence of cough or coryza. Again, patients meeting fewer criteria (0 to 1) are unlikely to have strep infections, while those meeting more criteria (4 or more) are more likely to be infected.<a class="bk_pop" href="#article-27105.r30">[30]</a> Clinical scoring systems for GABS are insufficiently sensitive or specific to eliminate the need for microbiologic testing in children and adolescents with suspected GABS.<a class="bk_pop" href="#article-27105.r31">[31]</a> The following list describes the parameters for testing in children and adolescents: </p><ul><li class="half_rhythm"><div>Children 3 years or older and adolescents with pharyngeal erythema, edema, and exudates or a scarlatiniform rash on physical examination</div></li><li class="half_rhythm"><div>Children younger than age 3 with prolonged nasal discharge, tender anterior cervical adenopathy, and a low-grade fever of 101 °F (38.3 °C) or less, especially if they have a known GABS exposure</div></li><li class="half_rhythm"><div>Children with suspected acute rheumatic fever or poststreptococcal glomerulonephritis</div></li><li class="half_rhythm"><div>Any child with a history of acute rheumatic fever and a household member with a GABS infection</div></li></ul><p>Patients who warrant testing for GABS can undergo either a sensitive RADT or a NAAT. Clinicians should collect specimens before beginning antimicrobial treatment and vigorously swab both tonsils or tonsillar fossae in patients without tonsils and the posterior pharynx. Accurate results are highly dependent on the collection of an adequate inoculum. Adults and older adolescents have a lower incidence of GABS pharyngitis than children and younger adolescents and an extremely low risk of developing acute rheumatic fever. Consequently, a follow-up throat culture for confirmation is unnecessary if either test returns a negative result. A confirmatory throat culture is necessary in children if the result of the GABS rapid test is negative.<a class="bk_pop" href="#article-27105.r32">[32]</a> </p><p>Given NAAT's high sensitivity and specificity, clinicians can also use it for confirmation. RADTs have a sensitivity of 77% to 92% and a specificity of 88% to 99%. However, solely using this test results in some false negative results unless clinicians follow with a confirmatory throat culture.<a class="bk_pop" href="#article-27105.r33">[33]</a> For this reason, adults who are at higher risk for severe infection or complications from GABS pharyngitis, closely interact with others at risk for complications, live in college dorms where acute rheumatic fever is endemic, or potentially have GABS despite a negative RADT result should undergo a throat culture or NAAT testing. Clinicians do not typically treat empirically while awaiting throat culture results.</p><p>
|
||
<b>Testing for other bacterial causes</b>
|
||
</p><p>Part of evaluating acute pharyngitis includes gathering historical information about sexual activity, potential blood-borne pathogen exposure, and recent intravenous drug use to assess the risk of HIV or other sexually transmitted infections. HIV and <i>N gonorrhea</i> are the 2 most frequent causes of sexually transmitted pharyngitis.</p><p>Symptoms of acute HIV infection include fever, pharyngitis, adenopathy in the cervical, axillary, and inguinal regions, headaches, myalgias, rash, and mucocutaneous ulcerations. Testing for suspected early HIV infection requires both a combination antigen/antibody test and an HIV viral load assessment. Clinicians should repeat testing in 1 to 2 weeks if initial tests are negative, but suspicion remains high. A negative antigen/antibody test with a positive HIV viral load suggests acute infection. A viral load of less than 100 copies/mL may indicate a false positive, necessitating repeat testing. A second positive viral load confirms infection.</p><p>Pharyngeal gonorrhea and chlamydia are often asymptomatic. Consequently, NAAT swab testing is recommended for patients at increased risk or when acute pharyngitis does not respond to standard treatment.<a class="bk_pop" href="#article-27105.r34">[34]</a> Culture serves as an alternative. Increased risk for syphilis infection is seen in men who have sex with men and patients with HIV. Syphilis screening traditionally starts with a nontreponemal test, such as the rapid plasma reagin (RPR) test, with confirmation using a treponemal test, like the fluorescent treponemal antibody absorption (FTA-ABS). More recent protocols reverse this order, beginning with a treponemal test, followed by a nontreponemal test for confirmation. This reverse method enhances the detection of early syphilis, cases previously treated, and late or late latent syphilis, where the nontreponemal test may become nonreactive over time.</p><p>Patients who do not respond to appropriate therapy may require a routine aerobic pharyngeal culture to test for group C or G streptococci, <i>A haemolyticum</i>, and <i>F necrophorum</i>. For suspected diphtheria, a culture should be obtained from both the membrane and beneath it. A presumptive diagnosis is supported by the appearance of gram-positive rods in a "Chinese character" distribution on gram stain, black colonies with halos on Tinsdale media, and metachromatic granules on Löffler media. Biochemical testing confirms the diagnosis, and additional testing for toxin production is necessary to differentiate toxigenic from nontoxigenic strains of <i>C. diphtheriae</i>. In cases of suspected tularemia, serology should be performed and repeated in 2 to 4 weeks.</p><p>
|
||
<b>Imaging</b>
|
||
</p><p>Imaging should be considered when clinical instability, difficulty swallowing, or restricted neck movement is observed. For epiglottitis, a plain radiograph typically shows an abnormal epiglottis. A retropharyngeal abscess may show some changes on plain radiographs, but computed tomography or magnetic resonance imaging is preferred for a more detailed evaluation. Radiographic findings often include increased thickness of the prevertebral soft tissue, swelling, and gas collections in the retropharyngeal space, leading to anterior displacement of the larynx and trachea.<a class="bk_pop" href="#article-27105.r35">[35]</a> Typically, the pharynx or upper airway is displaced anteriorly by more than half the width of the 4th cervical vertebral body.</p></div><div id="article-27105.s8"><h2 id="_article-27105_s8_">Treatment / Management</h2><p>The goals of treating bacterial pharyngitis are to relieve symptoms and prevent complications. Healthcare professionals do not treat the infection empirically but use the appropriate antibiotics after confirming the infection. Patients should also get adequate rest and fluids and eat a soft diet, taking nonsteroidal anti-inflammatory drugs (NSAIDs) for fever and pain relief. Studies reveal that NSAIDs are more effective than acetaminophen for symptom control.<a class="bk_pop" href="#article-27105.r36">[36]</a></p><p>
|
||
<b>Group A β-hemolytic <i>Streptococcus</i></b>
|
||
</p><p>The first-line treatment for children and adults with GABS is oral penicillin V. Amoxicillin is an acceptable alternative, and children may prefer it due to its taste. Penicillin is the only studied antibiotic shown to reduce the rates of acute rheumatic fever, and no documented cases of penicillin resistance exist. Patients with a history of acute rheumatic fever who are not on antibiotic prophylaxis receive oral penicillin V, amoxicillin, or a single dose of intramuscular penicillin G benzathine.<a class="bk_pop" href="#article-27105.r37">[37]</a> The recommended doses are stated below.</p><ul><li class="half_rhythm"><div>Adults: Oral penicillin V 500 mg 2 to 3 times/d for 10 days, oral amoxicillin 500 mg twice/d for 10 days, or intramuscular (IM) penicillin G benzathine 1.2 million U once</div></li><li class="half_rhythm"><div>Children:
|
||
<ul><li class="half_rhythm"><div>Oral penicillin V 250 mg 2 to 3 times/d for 10 days in patients weighing 27 kg or less</div></li><li class="half_rhythm"><div>Oral penicillin V 500 mg 2 to 3 times/d for 10 days in patients weighing more than 27 kg</div></li><li class="half_rhythm"><div>Oral amoxicillin 50 mg/kg/d to a maximum of 1000 mg/d for 10 days given daily or in 2 divided doses</div></li><li class="half_rhythm"><div>Penicillin G benzathine 600,000 units IM as a single dose in patients weighing 27 kg or less</div></li><li class="half_rhythm"><div>Penicillin G benzathine 1.2 million units IM as a single dose in patients weighing more than 27 kg</div></li></ul>
|
||
</div></li></ul><p>Despite symptom improvement within a few days, eradication from the oropharynx is more effective with a 10-day treatment compared to 5 to 7 days of use. Alternatives for patients who are allergic or unable to tolerate penicillin include cephalosporins, clindamycin, and macrolides. Cephalosporins are suitable in cases of mild penicillin allergy not mediated by immunoglobulin E or penicillin unavailability. Using a narrow-spectrum cephalosporin, such as cephalexin, helps avoid resistance. Azithromycin or clarithromycin is recommended in cases of severe penicillin allergy. The recommended doses are stated below.</p><ul><li class="half_rhythm"><div>Adults:
|
||
<ul><li class="half_rhythm"><div>Oral azithromycin 500 mg/d for 3 days </div></li><li class="half_rhythm"><div>Oral clarithromycin 250 mg twice/d for 10 days </div></li><li class="half_rhythm"><div>Oral clindamycin 300 mg 3 times/d for 10 days</div></li><li class="half_rhythm"><div>Oral cephalexin 500 mg twice/d for 10 days</div></li><li class="half_rhythm"><div>Oral cefuroxime 250 mg twice/d for 10 days</div></li></ul>
|
||
</div></li><li class="half_rhythm"><div>Children:
|
||
<ul><li class="half_rhythm"><div>Oral azithromycin 12 mg/kg/d maximum 500 mg/d for 3 days </div></li><li class="half_rhythm"><div>Oral clarithromycin 7.5 mg/kg/dose twice/d to a maximum of 250 mg per dose for 10 days</div></li><li class="half_rhythm"><div>Oral clindamycin 7 mg/kg/dose 3 times/d to a maximum of 300 mg per dose for 10 days</div></li><li class="half_rhythm"><div>Oral cephalexin 40 mg/kg/d divided twice daily for 10 days to a maximum of 500 mg/dose</div></li><li class="half_rhythm"><div>Oral cefuroxime 10 mg/kg/dose twice/d to a maximum of 250 mg/dose for 10 days </div></li></ul>
|
||
</div></li></ul><p>The macrolides azithromycin and clarithromycin have an increasing resistance rate and are associated with gastrointestinal symptoms and prolongation of the corrected QT interval, which may lead to torsades de pointes. Clindamycin also exhibits increasing resistance rates, and patients taking this medication often experience gastrointestinal adverse effects. The cephalosporins encompass a broader spectrum than penicillin and pose a more significant potential to create antibiotic resistance. Patients can return to work, school, or daycare 24 hours after starting antibiotics.</p><p>
|
||
<b>Other Bacterial Infections</b>
|
||
</p><p>Clinicians should treat pharyngeal gonorrhea or chlamydia infections the same way as a genital infection, with consideration for gonorrhea and chlamydia cotreatment. Gonorrhea therapeutic guidelines from the United States Centers for Disease Control and Prevention (CDC) include the following:</p><ul><li class="half_rhythm"><div>For individuals who weigh less than 150 kg, ceftriaxone 500 mg IM in a single dose</div></li><li class="half_rhythm"><div>For individuals weighing 150 kg or more, ceftriaxone 1 g IM in a single dose <a class="bk_pop" href="#article-27105.r38">[38]</a></div></li></ul><p>If concurrent NAAT testing for chlamydia is not performed, nonpregnant individuals should be treated with doxycycline 100 mg twice daily for 7 days. Azithromycin 1 g orally as a single dose or oral levofloxacin 500 mg/d may serve as an alternative to doxycycline for the treatment of chlamydia.  </p><p>Clinicians should report documented cases of diphtheria to the CDC. Treatment involves airway protection and management with a low threshold for intubation by a clinician experienced in obtaining and maintaining a challenging airway. Erythromycin or penicillin is the first-line antibiotic treatment. Antitoxin, obtained from the CDC, can reduce mortality from 7% to less than 1%.<a class="bk_pop" href="#article-27105.r39">[39]</a> Patients should be placed on respiratory droplet and contact isolation until therapy is complete, and 2 consecutive cultures taken from the nose and throat 24 hours apart both yield negative results.<a class="bk_pop" href="#article-27105.r40">[40]</a></p><p>Local infectious complications of acute pharyngitis, such as a peritonsillar abscess, should be managed in a hospital setting, where clinicians can intervene with appropriate surgical and specialist support. Patients with a peritonsillar abscess warrant antimicrobials, surgical drainage, and supportive care. More studies are needed before clinicians determine glucocorticoids' benefits in managing a peritonsillar abscess. Individuals with cellulitis can receive antimicrobials and supportive care alone. Patients with necrotizing fasciitis require immediate surgical exploration, debridement, and antimicrobials. In addition, individuals who develop toxic shock syndrome, marked by shock and multiorgan failure, should receive intravenous immune globulin along with surgical debridement and appropriate antimicrobial therapy.<a class="bk_pop" href="#article-27105.r41">[41]</a><a class="bk_pop" href="#article-27105.r42">[42]</a></p></div><div id="article-27105.s9"><h2 id="_article-27105_s9_">Differential Diagnosis</h2><p>As noted, most cases of acute pharyngitis are either noninfectious or viral. When evaluating the possibility of bacterial pharyngitis, healthcare professionals should also consider the following diagnoses:</p><ul><li class="half_rhythm"><div>Seasonal allergies</div></li><li class="half_rhythm"><div>Irritant pharyngitis due to gastroesophageal reflux disease or smoking</div></li><li class="half_rhythm"><div>Traumatic pharyngitis due to excessive shouting, snoring, or recent endotracheal intubation</div></li><li class="half_rhythm"><div>Aphthous ulcers</div></li><li class="half_rhythm"><div>Viral pharyngitis due to common viral respiratory pathogens like adenovirus, rhinovirus, or coronavirus</div></li><li class="half_rhythm"><div>Viral pharyngitis due to more serious pathogens like infectious mononucleosis or HIV</div></li><li class="half_rhythm"><div>Fungal infections such as esophageal candidiasis</div></li><li class="half_rhythm"><div>Lymphangitis</div></li><li class="half_rhythm"><div>Peritonsillar or retropharyngeal abscess</div></li><li class="half_rhythm"><div>Behçet syndrome</div></li><li class="half_rhythm"><div>Stevens-Johnson syndrome</div></li><li class="half_rhythm"><div>Kawasaki disease</div></li><li class="half_rhythm"><div>Foreign bodies lodged in the mucosal folds of the tonsils or pharynx</div></li><li class="half_rhythm"><div>Referred pain from otitis media, dental abscess, and cervical adenitis </div></li><li class="half_rhythm"><div>Lemierre syndrome</div></li><li class="half_rhythm"><div>Herpetic stomatitis</div></li><li class="half_rhythm"><div>Periodic fever with aphthous stomatitis, pharyngitis, and adenitis (PFAPA syndrome)</div></li><li class="half_rhythm"><div>Chemical exposure</div></li></ul><p>Careful clinical evaluation and diagnostic testing can guide treatment and improve outcomes.</p></div><div id="article-27105.s10"><h2 id="_article-27105_s10_">Prognosis</h2><p>Most cases of acute bacterial pharyngitis resolve spontaneously within 3 to 5 days without treatment. The exception is untreated pharyngeal gonorrhea, which takes approximately 16 weeks to resolve without treatment.<a class="bk_pop" href="#article-27105.r43">[43]</a> Successful treatment of confirmed GABS pharyngitis with the appropriate antibiotics generally leads to a favorable prognosis, with rare instances of associated complications.<a class="bk_pop" href="#article-27105.r44">[44]</a></p><p>Some patients may experience recurrent infections within a month postantibiotic treatment, often due to nonadherence to treatment or repeated exposure. In such cases, alternative antibiotics, often with broader coverage, such as amoxicillin-clavulanic acid, clindamycin, or intramuscular penicillin G, may be prescribed. Escalation to a 3rd-generation cephalosporin may be necessary if initial treatment involves a 1st-generation cephalosporin. Emphasizing the importance of adherence to treatment and minimizing risks is crucial in managing recurrent infections.</p><p>Sexually transmitted pharyngeal infections are easily treated and most commonly asymptomatic. The rare infections of diphtheria, tularemia, and plague are treatable when basic medical resources are available. However, these infections may have a poor prognosis since most cases develop in highly underresourced settings.<a class="bk_pop" href="#article-27105.r45">[45]</a> Diphtheria can have mortality rates in endemic regions, ranging from 3% to 20%, often due to resultant myocarditis or severely inadequate access to care.<a class="bk_pop" href="#article-27105.r46">[46]</a> Similarly, the mortality associated with <i>Y. pestis</i> ranges from less than 15% when treated to 60% to 100% when left untreated.<a class="bk_pop" href="#article-27105.r47">[47]</a></p></div><div id="article-27105.s11"><h2 id="_article-27105_s11_">Complications</h2><p>Complications of bacterial pharyngitis generally include the following:</p><ul><li class="half_rhythm"><div>Peritonsillar abscess</div></li><li class="half_rhythm"><div>Sinusitis</div></li><li class="half_rhythm"><div>Necrotizing fasciitis</div></li><li class="half_rhythm"><div>Submandibular abscesss</div></li><li class="half_rhythm"><div>Retropharyngeal abscess</div></li><li class="half_rhythm"><div>Parapharyngeal space infection</div></li><li class="half_rhythm"><div>Suppurative jugular thrombophlebitis or Lemiere syndrome due to bacterial invasion and clot formation of the jugular vein</div></li><li class="half_rhythm"><div>Epiglottitis</div></li><li class="half_rhythm"><div>Meningitis</div></li><li class="half_rhythm"><div>Mastoiditis</div></li><li class="half_rhythm"><div>Sepsis</div></li><li class="half_rhythm"><div>Pyomyositis</div></li><li class="half_rhythm"><div><i>Clostridioides</i> <i>difficile</i> colitis <a class="bk_pop" href="#article-27105.r48">[48]</a><a class="bk_pop" href="#article-27105.r49">[49]</a></div></li></ul><p>Physical examination findings of systemic toxicity, midline or unilateral swelling, or bulging of the posterior pharyngeal wall associated with sore throat, difficulty swallowing, and difficulty breathing may signify a retropharyngeal abscess. Trismus, induration, swelling below the mandibular angle, medial pharyngeal wall bulging, and systemic toxicity indicate a parapharyngeal space infection. Patients may also experience facial and cervical swelling and erythema, parotid gland swelling and displacement, and purulent oral discharge since dental abscesses are the most common underlying cause. A peritonsillar abscess manifests as a high fever, odynophagia, unilateral sore throat, and otalgia. Classic signs include a muffled voice, trismus, unilateral deviation of the uvula toward the unaffected side, and soft palate fullness or edema.</p><p>Patients with necrotizing fasciitis typically present with pain disproportionate to the examination findings, poorly defined erythema, edema extending beyond the area of erythema, fever, and the presence of skin bullae, necrosis, or ecchymosis. A characteristic finding is a diminished sensation of pain in the affected area. </p><p>As noted above, GABS pharyngitis can lead to suppurative complications, which encompass the extension of infection beyond the oropharynx, as well as nonsuppurative complications. Nonsuppurative complications are immune phenomena and include the following:</p><ul><li class="half_rhythm"><div>Acute rheumatic fever</div></li><li class="half_rhythm"><div>Poststreptococcal reactive arthritis</div></li><li class="half_rhythm"><div>Scarlet fever</div></li><li class="half_rhythm"><div>Acute glomerulonephritis</div></li><li class="half_rhythm"><div>Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS)</div></li><li class="half_rhythm"><div>Toxic shock syndrome</div></li></ul><p>The onset of acute rheumatic fever occurs 2 to 4 weeks following GABS infection, and patients may experience arthritis, carditis, chorea, subcutaneous nodules, and erythema marginatum. Most patients present with an acute febrile illness with joint manifestations and, often, carditis. The diagnosis is clinical, based on the presence of major and minor criteria. See StatPearls' companion reference, "<a href="https://www.statpearls.com/point-of-care/155742" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Acute Rheumatic Fever</a>," for additional information. The most common long-term outcome is rheumatic heart disease, occurring 10 to 20 years later. See StatPearls' companion reference, "<a href="https://www.statpearls.com/point-of-care/28514" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Rheumatic Heart Disease</a>," for additional information regarding the presentation and long-term sequelae of rheumatic heart disease.</p><p>Scarlet fever, caused by a delayed-type skin reactivity to an exotoxin produced by the organism, requires previous exposure and presents with 1- to 2-mm papular eruptions with a sandpaper-like feel. See StatPearls' companion reference, "<a href="https://www.statpearls.com/point-of-care/28741" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Scarlet Fever</a>," for additional information. PANDAS occurs in a subset of children whose symptoms of obsessive-compulsive disorder, tic disorders, or other neuropsychiatric symptoms like anxiety are exacerbated by GABS infection. PANDAS is a subset of pediatric acute-onset neuropsychiatric syndrome (PANS) thought sometimes to be brought on by various pathogens, including GABS.<a class="bk_pop" href="#article-27105.r50">[50]</a> See StatPearls' additional companion references, "<a href="https://www.statpearls.com/point-of-care/30298" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Toxic Shock Syndrome</a> and <a href="https://www.statpearls.com/point-of-care/22287" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Poststreptococcal Glomerulonephritis</a>," for further information regarding these nonsuppurative complications of GABS pharyngitis.</p><p>Pharyngeal sexually transmitted infections, such as gonorrhea and chlamydia, rarely cause complications, with 0.5% to 3% of all patients infected with <i>N. gonorrhea</i> in any location developing disseminated gonorrhea. Pharyngeal infections are contagious, increasing the risk of infection for sexual partners who can develop symptoms and cause complications like pelvic inflammatory disease, orchitis, and prostatitis.<a class="bk_pop" href="#article-27105.r51">[51]</a></p><p>Patients with diphtheria may experience respiratory compromise through swelling of the upper airway, cardiovascular compromise through toxin-induced myocarditis, renal failure, and local or systemic paralysis due to neurologic toxicity.<a class="bk_pop" href="#article-27105.r52">[52]</a></p><p>Potential complications associated with tularemia are sepsis, renal failure, rhabdomyolysis, and hepatitis. Rarely, <i>F. tularensis</i> infection may cause otitis media and mastoiditis, endocarditis, pericarditis, myocarditis, meningitis, osteomyelitis, peritonitis, granulomatous hepatitis, spontaneous splenic rupture, and aortitis.<a class="bk_pop" href="#article-27105.r53">[53]</a><a class="bk_pop" href="#article-27105.r54">[54]</a> </p><p>Pharyngitis due to <i>Y. pestis</i> hints at a potential site of inoculation and may not represent a typical initial presentation of plague. Patients who do not develop the typical bubos are challenging to diagnose and may develop meningitis, multiorgan failure, and death.<a class="bk_pop" href="#article-27105.r55">[55]</a><a class="bk_pop" href="#article-27105.r56">[56]</a></p></div><div id="article-27105.s12"><h2 id="_article-27105_s12_">Deterrence and Patient Education</h2><p>Most infectious acute pharyngitis cases are due to respiratory viral pathogens, and symptomatic treatment alone is adequate. Information on supportive measures such as rest, hydration, and pain relief options can empower patients to manage their symptoms effectively. Patients can reduce the incidence of bacterial pharyngitis with proper hygiene protocols, such as handwashing, avoiding sharing food or beverages, and covering the mouth while coughing and sneezing. </p><p>Accurate identification of bacterial pharyngitis is critical to avoid unnecessary testing, treatment, and potential complications from untreated infections. Avoiding unnecessary antibiotic use and promoting patient education in bacterial pharyngitis management are essential roles for clinicians. Most cases of bacterial pharyngitis resolve spontaneously after 3 to 5 days. However, bacterial pharyngitis should be treated with the appropriate antibiotics to prevent suppurative and nonsuppurative complications associated with GABS pharyngitis.</p><p>Patients should know the potential complications of GABS pharyngitides, such as acute rheumatic fever, poststreptococcal glomerulonephritis, and retropharyngeal abscess, and the symptoms that should prompt an immediate call to their healthcare professional. Healthcare providers must educate patients on the importance of adhering to the prescribed treatment regimens, completing the entire course of antibiotics, and avoiding sharing medications. Proper patient education can help prevent complications and recurrent infections and minimize the spread of antibiotic-resistant bacteria. Adults and children may return to work, school, or daycare 24 hours after beginning antibiotics.</p></div><div id="article-27105.s13"><h2 id="_article-27105_s13_">Enhancing Healthcare Team Outcomes </h2><p>Pharyngitis, characterized by inflammation of the pharynx leading to a sore throat, often stems from noninfectious causes or viral respiratory pathogens. However, bacterial causes also present a significant risk due to potential complications. The risk of complications necessitates a comprehensive assessment to discern between common, uncommon, and life-threatening origins. Distinguishing between viral and bacterial pharyngitis may prove challenging as symptoms can overlap. Accurate recognition of bacterial pharyngitis is essential to prevent unnecessary tests and treatments, as well as potential complications from untreated infections.</p><p>The initial history and physical examination help exclude life-threatening conditions and identify treatable causes of pharyngitis. Patients with bacterial pharyngitis are at risk for severe complications, and healthcare professionals caring for patients with acute pharyngitis must be adept at distinguishing between viral and bacterial causes. </p><p>Differentiating between viral and bacterial pharyngitis relies on clinical evaluation and appropriate testing, such as that for GABS. The Centor criteria and other clinical decision rules assist in determining which adult patients warrant testing for GABS. Clinical decision rules are not reliable predictors for children with pharyngitis. Additionally, testing for other bacterial causes, such as sexually transmitted infections, may be necessary based on risk factors and symptoms.</p><p>Physicians and advanced practitioners utilize their clinical skills to accurately identify the condition, determine appropriate diagnostic tests, prescribe antibiotics when necessary, and manage potential complications. These healthcare professionals should use evidence-based guidelines, such as the Centor criteria, to guide testing and treatment decisions effectively.</p><p>Nurses are crucial in patient education and support, ensuring correct sampling for rapid testing and bacterial cultures and facilitating communication between patients and other healthcare team members. Pharmacists also educate patients about antibiotic use, including dosage, frequency, and potential side effects, to promote adherence and minimize the development of antibiotic resistance. Clinicians reserve imaging for cases of clinical instability or suspected complications. By employing a comprehensive evaluation approach and appropriate diagnostic strategies, clinicians can accurately diagnose bacterial pharyngitis, tailor treatment effectively, and minimize the risk of complications.</p><p>Interprofessional communication is essential for effective collaboration and coordination of care. Healthcare professionals must communicate efficiently and accurately to ensure patients receive timely and appropriate treatment. Team members must share relevant patient information, discuss treatment plans, and address concerns or questions during care. By leveraging their skills, implementing effective strategies, fostering interprofessional communication, and coordinating care, physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals can enhance patient-centered care, improve outcomes, promote patient safety, and optimize team performance in managing bacterial pharyngitis.</p></div><div id="article-27105.s14"><h2 id="_article-27105_s14_">Review Questions</h2><ul><li class="half_rhythm"><div>
|
||
<a href="https://www.statpearls.com/account/trialuserreg/?articleid=27105&utm_source=pubmed&utm_campaign=reviews&utm_content=27105" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Access free multiple choice questions on this topic.</a>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<a href="https://mdsearchlight.com/infectious-disease/bacterial-pharyngitis-strep-throat-pharyngitis/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=27105" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Click here for a simplified version.</a>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<a href="https://www.statpearls.com/articlelibrary/commentarticle/27105/?utm_source=pubmed&utm_campaign=comments&utm_content=27105" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Comment on this article.</a>
|
||
</div></li></ul></div><div id="article-27105.s15"><h2 id="_article-27105_s15_">References</h2><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="article-27105.r1">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C., Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. <span><span class="ref-journal">Clin Infect Dis. </span>2012 Nov 15;<span class="ref-vol">55</span>(10):e86-102.</span> [<a href="/pmc/articles/PMC7108032/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7108032</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22965026" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22965026</span></a>]</div></dd><dt>2.</dt><dd><div class="bk_ref" id="article-27105.r2">Renner B, Mueller CA, Shephard A. Environmental and non-infectious factors in the aetiology of pharyngitis (sore throat). <span><span class="ref-journal">Inflamm Res. </span>2012 Oct;<span class="ref-vol">61</span>(10):1041-52.</span> [<a href="/pmc/articles/PMC3439613/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3439613</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22890476" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22890476</span></a>]</div></dd><dt>3.</dt><dd><div class="bk_ref" id="article-27105.r3">Kalra MG, Higgins KE, Perez ED. Common Questions About Streptococcal Pharyngitis. <span><span class="ref-journal">Am Fam Physician. </span>2016 Jul 01;<span class="ref-vol">94</span>(1):24-31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27386721" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27386721</span></a>]</div></dd><dt>4.</dt><dd><div class="bk_ref" id="article-27105.r4">Patton ME, Kidd S, Llata E, Stenger M, Braxton J, Asbel L, Bernstein K, Gratzer B, Jespersen M, Kerani R, Mettenbrink C, Mohamed M, Pathela P, Schumacher C, Stirland A, Stover J, Tabidze I, Kirkcaldy RD, Weinstock H. Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012. <span><span class="ref-journal">Clin Infect Dis. </span>2014 Jun;<span class="ref-vol">58</span>(11):1564-70.</span> [<a href="/pmc/articles/PMC4666527/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4666527</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24647015" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24647015</span></a>]</div></dd><dt>5.</dt><dd><div class="bk_ref" id="article-27105.r5">Butler T. Plague gives surprises in the first decade of the 21st century in the United States and worldwide. <span><span class="ref-journal">Am J Trop Med Hyg. </span>2013 Oct;<span class="ref-vol">89</span>(4):788-93.</span> [<a href="/pmc/articles/PMC3795114/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3795114</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24043686" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24043686</span></a>]</div></dd><dt>6.</dt><dd><div class="bk_ref" id="article-27105.r6">Galazka AM, Robertson SE. Diphtheria: changing patterns in the developing world and the industrialized world. <span><span class="ref-journal">Eur J Epidemiol. </span>1995 Feb;<span class="ref-vol">11</span>(1):107-17.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7489768" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7489768</span></a>]</div></dd><dt>7.</dt><dd><div class="bk_ref" id="article-27105.r7">O'Boyle S, Barton HE, D'Aeth JC, Cordery R, Fry NK, Litt D, Southgate R, Verrecchia R, Mannes T, Wang TY, Stewart DE, Olufon O, Dickinson M, Ramsay ME, Amirthalingam G. National public health response to an outbreak of toxigenic Corynebacterium diphtheriae among asylum seekers in England, 2022: a descriptive epidemiological study. <span><span class="ref-journal">Lancet Public Health. </span>2023 Oct;<span class="ref-vol">8</span>(10):e766-e775.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37777286" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37777286</span></a>]</div></dd><dt>8.</dt><dd><div class="bk_ref" id="article-27105.r8">Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. <span><span class="ref-journal">Natl Health Stat Report. </span>2008 Aug 06;(8):1-29.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18958997" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18958997</span></a>]</div></dd><dt>9.</dt><dd><div class="bk_ref" id="article-27105.r9">André M, Odenholt I, Schwan A, Axelsson I, Eriksson M, Hoffman M, Mölstad S, Runehagen A, Lundborg CS, Wahlström R., Swedish Study Group on Antibiotic Use. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. <span><span class="ref-journal">Scand J Infect Dis. </span>2002;<span class="ref-vol">34</span>(12):880-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12587619" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12587619</span></a>]</div></dd><dt>10.</dt><dd><div class="bk_ref" id="article-27105.r10">Danchin MH, Rogers S, Kelpie L, Selvaraj G, Curtis N, Carlin JB, Nolan TM, Carapetis JR. Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. <span><span class="ref-journal">Pediatrics. </span>2007 Nov;<span class="ref-vol">120</span>(5):950-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17974731" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17974731</span></a>]</div></dd><dt>11.</dt><dd><div class="bk_ref" id="article-27105.r11">Varosy PD, Newman TB. Acute pharyngitis. <span><span class="ref-journal">N Engl J Med. </span>2001 May 10;<span class="ref-vol">344</span>(19):1479; author reply 1480.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11357847" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11357847</span></a>]</div></dd><dt>12.</dt><dd><div class="bk_ref" id="article-27105.r12">Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. <span><span class="ref-journal">Heart. </span>2008 Dec;<span class="ref-vol">94</span>(12):1534-40.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18669552" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18669552</span></a>]</div></dd><dt>13.</dt><dd><div class="bk_ref" id="article-27105.r13">Kogler A, Sadoghi B, Draschl A, Chromy D, Binder L, Schiefer-Niederkorn A, Hofmann-Wellenhof EL, Wolf P. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium at pharyngeal and anorectal sites in patients presenting to an STI outpatient ward. <span><span class="ref-journal">J Eur Acad Dermatol Venereol. </span>2024 Apr 12;</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38606611" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38606611</span></a>]</div></dd><dt>14.</dt><dd><div class="bk_ref" id="article-27105.r14">Carville KS, Meagher N, Abo YN, Manski-Nankervis JA, Fielding J, Steer A, McVernon J, Price DJ. Burden of antimicrobial prescribing in primary care attributable to sore throat: a retrospective cohort study of patient record data. <span><span class="ref-journal">BMC Prim Care. </span>2024 Apr 17;<span class="ref-vol">25</span>(1):117.</span> [<a href="/pmc/articles/PMC11022400/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC11022400</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38632513" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38632513</span></a>]</div></dd><dt>15.</dt><dd><div class="bk_ref" id="article-27105.r15">Fischetti VA. Streptococcal M protein. <span><span class="ref-journal">Sci Am. </span>1991 Jun;<span class="ref-vol">264</span>(6):58-65.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1857955" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1857955</span></a>]</div></dd><dt>16.</dt><dd><div class="bk_ref" id="article-27105.r16">Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. <span><span class="ref-journal">N Engl J Med. </span>2017 Dec 07;<span class="ref-vol">377</span>(23):2253-2265.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29211672" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29211672</span></a>]</div></dd><dt>17.</dt><dd><div class="bk_ref" id="article-27105.r17">Lottenberg R, Broder CC, Boyle MD. Identification of a specific receptor for plasmin on a group A streptococcus. <span><span class="ref-journal">Infect Immun. </span>1987 Aug;<span class="ref-vol">55</span>(8):1914-8.</span> [<a href="/pmc/articles/PMC260624/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC260624</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3038753" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3038753</span></a>]</div></dd><dt>18.</dt><dd><div class="bk_ref" id="article-27105.r18">Hurst JR, Brouwer S, Walker MJ, McCormick JK. Streptococcal superantigens and the return of scarlet fever. <span><span class="ref-journal">PLoS Pathog. </span>2021 Dec;<span class="ref-vol">17</span>(12):e1010097.</span> [<a href="/pmc/articles/PMC8717983/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8717983</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34969060" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34969060</span></a>]</div></dd><dt>19.</dt><dd><div class="bk_ref" id="article-27105.r19">Hughes-Games A, Davis SA, Hill DJ. Direct visualization of sequence-specific DNA binding by gonococcal type IV pili. <span><span class="ref-journal">Microbiology (Reading). </span>2022 Aug;<span class="ref-vol">168</span>(8)</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35920810" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 35920810</span></a>]</div></dd><dt>20.</dt><dd><div class="bk_ref" id="article-27105.r20">Yavlovich A, Tarshis M, Rottem S. Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells. <span><span class="ref-journal">FEMS Microbiol Lett. </span>2004 Apr 15;<span class="ref-vol">233</span>(2):241-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15063492" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15063492</span></a>]</div></dd><dt>21.</dt><dd><div class="bk_ref" id="article-27105.r21">Taylor A, Webb R. Fifteen-minute consultation: Group A streptococcal pharyngitis, diagnosis and treatment in children. <span><span class="ref-journal">Arch Dis Child Educ Pract Ed. </span>2024 Sep 19;<span class="ref-vol">109</span>(5):210-221.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38514137" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38514137</span></a>]</div></dd><dt>22.</dt><dd><div class="bk_ref" id="article-27105.r22">Chapel TA. The signs and symptoms of secondary syphilis. <span><span class="ref-journal">Sex Transm Dis. </span>1980 Oct-Dec;<span class="ref-vol">7</span>(4):161-4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7455863" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7455863</span></a>]</div></dd><dt>23.</dt><dd><div class="bk_ref" id="article-27105.r23">Braun GS, Wagner KS, Huttner BD, Schmid H. Mycoplasma pneumoniae: usual suspect and unsecured diagnosis in the acute setting. <span><span class="ref-journal">J Emerg Med. </span>2006 May;<span class="ref-vol">30</span>(4):371-5.</span> [<a href="/pmc/articles/PMC7126277/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7126277</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16740444" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16740444</span></a>]</div></dd><dt>24.</dt><dd><div class="bk_ref" id="article-27105.r24">Sharma R, Patil RD, Singh B, Chakraborty S, Chandran D, Dhama K, Gopinath D, Jairath G, Rialch A, Mal G, Singh P, Chaicumpa W, Saikumar G. Tularemia - a re-emerging disease with growing concern. <span><span class="ref-journal">Vet Q. </span>2023 Dec;<span class="ref-vol">43</span>(1):1-16.</span> [<a href="/pmc/articles/PMC10732219/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10732219</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37916743" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37916743</span></a>]</div></dd><dt>25.</dt><dd><div class="bk_ref" id="article-27105.r25">Crook LD, Tempest B. Plague. A clinical review of 27 cases. <span><span class="ref-journal">Arch Intern Med. </span>1992 Jun;<span class="ref-vol">152</span>(6):1253-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1599354" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1599354</span></a>]</div></dd><dt>26.</dt><dd><div class="bk_ref" id="article-27105.r26">Ebell MH, Smith MA, Barry HC, Ives K, Carey M. The rational clinical examination. Does this patient have strep throat? <span><span class="ref-journal">JAMA. </span>2000 Dec 13;<span class="ref-vol">284</span>(22):2912-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11147989" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11147989</span></a>]</div></dd><dt>27.</dt><dd><div class="bk_ref" id="article-27105.r27">Haynes MA, Temkit M, Kushner I, Hindman DE. Appropriateness of Use of Streptococcal Pharyngitis Testing and Associated Antibiotic Prescribing in the Urgent Care Setting. <span><span class="ref-journal">Clin Pediatr (Phila). </span>2024 Dec;<span class="ref-vol">63</span>(12):1691-1697.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38469805" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38469805</span></a>]</div></dd><dt>28.</dt><dd><div class="bk_ref" id="article-27105.r28">Kanagasabai A, Evans C, Jones HE, Hay AD, Dawson S, Savović J, Elwenspoek MMC. Systematic review and meta-analysis of the accuracy of McIsaac and Centor score in patients presenting to secondary care with pharyngitis. <span><span class="ref-journal">Clin Microbiol Infect. </span>2024 Apr;<span class="ref-vol">30</span>(4):445-452.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38182052" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38182052</span></a>]</div></dd><dt>29.</dt><dd><div class="bk_ref" id="article-27105.r29">Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. <span><span class="ref-journal">Arch Intern Med. </span>2012 Jun 11;<span class="ref-vol">172</span>(11):847-52.</span> [<a href="/pmc/articles/PMC3627733/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3627733</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22566485" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22566485</span></a>]</div></dd><dt>30.</dt><dd><div class="bk_ref" id="article-27105.r30">Little P, Hobbs FD, Moore M, Mant D, Williamson I, McNulty C, Lasseter G, Cheng MY, Leydon G, McDermott L, Turner D, Pinedo-Villanueva R, Raftery J, Glasziou P, Mullee M., PRISM investigators. PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study. <span><span class="ref-journal">Health Technol Assess. </span>2014 Jan;<span class="ref-vol">18</span>(6):vii-xxv, 1-101.</span> [<a href="/pmc/articles/PMC4781545/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4781545</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24467988" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24467988</span></a>]</div></dd><dt>31.</dt><dd><div class="bk_ref" id="article-27105.r31">Roggen I, van Berlaer G, Gordts F, Pierard D, Hubloue I. Centor criteria in children in a paediatric emergency department: for what it is worth. <span><span class="ref-journal">BMJ Open. </span>2013;<span class="ref-vol">3</span>(4)</span> [<a href="/pmc/articles/PMC3641432/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3641432</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23613571" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23613571</span></a>]</div></dd><dt>32.</dt><dd><div class="bk_ref" id="article-27105.r32">Thompson TZ, McMullen AR. Group A Streptococcus Testing in Pediatrics: the Move to Point-of-Care Molecular Testing. <span><span class="ref-journal">J Clin Microbiol. </span>2020 May 26;<span class="ref-vol">58</span>(6)</span> [<a href="/pmc/articles/PMC7269410/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7269410</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32161094" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32161094</span></a>]</div></dd><dt>33.</dt><dd><div class="bk_ref" id="article-27105.r33">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. <span><span class="ref-journal">Clin Infect Dis. </span>2012 Nov 15;<span class="ref-vol">55</span>(10):1279-82.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23091044" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23091044</span></a>]</div></dd><dt>34.</dt><dd><div class="bk_ref" id="article-27105.r34">Workowski KA, Bolan GA., Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. <span><span class="ref-journal">MMWR Recomm Rep. </span>2015 Jun 05;<span class="ref-vol">64</span>(RR-03):1-137.</span> [<a href="/pmc/articles/PMC5885289/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5885289</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26042815" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26042815</span></a>]</div></dd><dt>35.</dt><dd><div class="bk_ref" id="article-27105.r35">Galioto NJ. Peritonsillar Abscess. <span><span class="ref-journal">Am Fam Physician. </span>2017 Apr 15;<span class="ref-vol">95</span>(8):501-506.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28409615" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28409615</span></a>]</div></dd><dt>36.</dt><dd><div class="bk_ref" id="article-27105.r36">Gehanno P, Dreiser RL, Ionescu E, Gold M, Liu JM. Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat. <span><span class="ref-journal">Clin Drug Investig. </span>2003;<span class="ref-vol">23</span>(4):263-71.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17535039" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17535039</span></a>]</div></dd><dt>37.</dt><dd><div class="bk_ref" id="article-27105.r37">Smith KL, Hughes R, Myrex P. Tonsillitis and Tonsilloliths: Diagnosis and Management. <span><span class="ref-journal">Am Fam Physician. </span>2023 Jan;<span class="ref-vol">107</span>(1):35-41.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36689967" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 36689967</span></a>]</div></dd><dt>38.</dt><dd><div class="bk_ref" id="article-27105.r38">Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. <span><span class="ref-journal">MMWR Recomm Rep. </span>2021 Jul 23;<span class="ref-vol">70</span>(4):1-187.</span> [<a href="/pmc/articles/PMC8344968/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8344968</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34292926" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34292926</span></a>]</div></dd><dt>39.</dt><dd><div class="bk_ref" id="article-27105.r39">Eisenberg N, Panunzi I, Wolz A, Burzio C, Cilliers A, Islam MA, Noor WM, Jalon O, Jannat-Khah D, Gil Cuesta J. Diphtheria Antitoxin Administration, Outcomes, and Safety: Response to a Diphtheria Outbreak in Cox's Bazar, Bangladesh. <span><span class="ref-journal">Clin Infect Dis. </span>2021 Oct 05;<span class="ref-vol">73</span>(7):e1713-e1718.</span> [<a href="/pmc/articles/PMC8561263/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8561263</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33245364" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 33245364</span></a>]</div></dd><dt>40.</dt><dd><div class="bk_ref" id="article-27105.r40">Farizo KM, Strebel PM, Chen RT, Kimbler A, Cleary TJ, Cochi SL. Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. <span><span class="ref-journal">Clin Infect Dis. </span>1993 Jan;<span class="ref-vol">16</span>(1):59-68.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8448320" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8448320</span></a>]</div></dd><dt>41.</dt><dd><div class="bk_ref" id="article-27105.r41">Kadri SS, Swihart BJ, Bonne SL, Hohmann SF, Hennessy LV, Louras P, Evans HL, Rhee C, Suffredini AF, Hooper DC, Follmann DA, Bulger EM, Danner RL. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals. <span><span class="ref-journal">Clin Infect Dis. </span>2017 Apr 01;<span class="ref-vol">64</span>(7):877-885.</span> [<a href="/pmc/articles/PMC5850528/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5850528</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28034881" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28034881</span></a>]</div></dd><dt>42.</dt><dd><div class="bk_ref" id="article-27105.r42">Madsen MB, Hjortrup PB, Hansen MB, Lange T, Norrby-Teglund A, Hyldegaard O, Perner A. Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. <span><span class="ref-journal">Intensive Care Med. </span>2017 Nov;<span class="ref-vol">43</span>(11):1585-1593.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28421246" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28421246</span></a>]</div></dd><dt>43.</dt><dd><div class="bk_ref" id="article-27105.r43">Barbee LA, Soge OO, Khosropour CM, Haglund M, Yeung W, Hughes J, Golden MR. The Duration of Pharyngeal Gonorrhea: A Natural History Study. <span><span class="ref-journal">Clin Infect Dis. </span>2021 Aug 16;<span class="ref-vol">73</span>(4):575-582.</span> [<a href="/pmc/articles/PMC8366826/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8366826</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33513222" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 33513222</span></a>]</div></dd><dt>44.</dt><dd><div class="bk_ref" id="article-27105.r44">WANNAMAKER LW, RAMMELKAMP CH, DENNY FW, BRINK WR, HOUSER HB, HAHN EO, DINGLE JH. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. <span><span class="ref-journal">Am J Med. </span>1951 Jun;<span class="ref-vol">10</span>(6):673-95.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14837911" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14837911</span></a>]</div></dd><dt>45.</dt><dd><div class="bk_ref" id="article-27105.r45">Koirala J. Plague: disease, management, and recognition of act of terrorism. <span><span class="ref-journal">Infect Dis Clin North Am. </span>2006 Jun;<span class="ref-vol">20</span>(2):273-87, viii.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16762739" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16762739</span></a>]</div></dd><dt>46.</dt><dd><div class="bk_ref" id="article-27105.r46">Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. <span><span class="ref-journal">J Infect Dis. </span>2000 Feb;<span class="ref-vol">181 Suppl 1</span>:S110-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10657201" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10657201</span></a>]</div></dd><dt>47.</dt><dd><div class="bk_ref" id="article-27105.r47">Campbell GL, Hughes JM. Plague in India: a new warning from an old nemesis. <span><span class="ref-journal">Ann Intern Med. </span>1995 Jan 15;<span class="ref-vol">122</span>(2):151-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7992992" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7992992</span></a>]</div></dd><dt>48.</dt><dd><div class="bk_ref" id="article-27105.r48">Bhavsar SM. Group A Streptococcus Infections. <span><span class="ref-journal">Pediatr Rev. </span>2024 Mar 01;<span class="ref-vol">45</span>(3):143-151.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38425166" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38425166</span></a>]</div></dd><dt>49.</dt><dd><div class="bk_ref" id="article-27105.r49">Bathala S, Eccles R. A review on the mechanism of sore throat in tonsillitis. <span><span class="ref-journal">J Laryngol Otol. </span>2013 Mar;<span class="ref-vol">127</span>(3):227-32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23317998" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23317998</span></a>]</div></dd><dt>50.</dt><dd><div class="bk_ref" id="article-27105.r50">Gagliano A, Carta A, Tanca MG, Sotgiu S. Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives. <span><span class="ref-journal">Neuropsychiatr Dis Treat. </span>2023;<span class="ref-vol">19</span>:1221-1250.</span> [<a href="/pmc/articles/PMC10225150/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10225150</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37251418" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 37251418</span></a>]</div></dd><dt>51.</dt><dd><div class="bk_ref" id="article-27105.r51">Eschenbach DA, Buchanan TM, Pollock HM, Forsyth PS, Alexander ER, Lin JS, Wang SP, Wentworth BB, MacCormack WM, Holmes KK. Polymicrobial etiology of acute pelvic inflammatory disease. <span><span class="ref-journal">N Engl J Med. </span>1975 Jul 24;<span class="ref-vol">293</span>(4):166-71.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/806017" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 806017</span></a>]</div></dd><dt>52.</dt><dd><div class="bk_ref" id="article-27105.r52">Dobie RA, Tobey DN. Clinical features of diphtheria in the respiratory tract. <span><span class="ref-journal">JAMA. </span>1979 Nov 16;<span class="ref-vol">242</span>(20):2197-201.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/490806" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 490806</span></a>]</div></dd><dt>53.</dt><dd><div class="bk_ref" id="article-27105.r53">Kara SS, Polat M, Erdeniz EH, Donmez AS. Pediatric Oropharyngeal Tularemia Cases: Challenges in Management. <span><span class="ref-journal">Vector Borne Zoonotic Dis. </span>2024 Sep;<span class="ref-vol">24</span>(9):585-590.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38651622" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38651622</span></a>]</div></dd><dt>54.</dt><dd><div class="bk_ref" id="article-27105.r54">Abalos C, Cutrona A, John J. Lessons Learned From a Young Lady With a Bad Sore Throat. <span><span class="ref-journal">Am J Med. </span>2021 Jan;<span class="ref-vol">134</span>(1):54-56.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32505702" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32505702</span></a>]</div></dd><dt>55.</dt><dd><div class="bk_ref" id="article-27105.r55">Welty TK, Grabman J, Kompare E, Wood G, Welty E, Van Duzen J, Rudd P, Poland J. Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. <span><span class="ref-journal">West J Med. </span>1985 May;<span class="ref-vol">142</span>(5):641-6.</span> [<a href="/pmc/articles/PMC1306131/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1306131</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4013279" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 4013279</span></a>]</div></dd><dt>56.</dt><dd><div class="bk_ref" id="article-27105.r56">Arbaji A, Kharabsheh S, Al-Azab S, Al-Kayed M, Amr ZS, Abu Baker M, Chu MC. A 12-case outbreak of pharyngeal plague following the consumption of camel meat, in north-eastern Jordan. <span><span class="ref-journal">Ann Trop Med Parasitol. </span>2005 Dec;<span class="ref-vol">99</span>(8):789-93.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16297292" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16297292</span></a>]</div></dd></dl></div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_top_margin">
|
||
<b>Disclosure: </b>Seneca Harberger declares no relevant financial relationships with ineligible companies.</p></div></dd><dt></dt><dd><div><p class="no_top_margin">
|
||
<b>Disclosure: </b>Jennifer Goldin declares no relevant financial relationships with ineligible companies.</p></div></dd><dt></dt><dd><div><p class="no_top_margin">
|
||
<b>Disclosure: </b>Matthew Graber declares no relevant financial relationships with ineligible companies.</p></div></dd></dl></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 2025, StatPearls Publishing LLC.<p class="small">
|
||
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
|
||
(<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=uri">
|
||
http://creativecommons.org/licenses/by-nc-nd/4.0/
|
||
</a>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
|
||
</p></div><div class="small"><span class="label">Bookshelf ID: NBK559007</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32644433" title="PubMed record of this page" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">32644433</a></span></div></div></div>
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK559007&ncbi_domain=statpearls&ncbi_report=printable&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK559007/?report=printable&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal105 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |